Compare Ginkgo Bioworks Holdings Inc (DNA) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Enveric Biosciences Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 81.6× Enveric Biosciences Inc's market cap, and Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| DNA | ENVB | |
|---|---|---|
Market Cap | $505.73M | $6.20M |
Sector | Health | Health |
52-Week High | $16.14 | $17.40 |
52-Week Low | $5.48 | $1.27 |
Enterprise Value | $607.68M | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
